IS6620A - Nýr fjölgervingur V af tórasemíði - Google Patents

Nýr fjölgervingur V af tórasemíði

Info

Publication number
IS6620A
IS6620A IS6620A IS6620A IS6620A IS 6620 A IS6620 A IS 6620A IS 6620 A IS6620 A IS 6620A IS 6620 A IS6620 A IS 6620A IS 6620 A IS6620 A IS 6620A
Authority
IS
Iceland
Prior art keywords
torazemide
polyphenyl
new
new polyphenyl
Prior art date
Application number
IS6620A
Other languages
English (en)
Inventor
Filic Darko
Dumic Miljenko
Klepic Bozena
Danilovski Aleksandar
Tudja Marijan
Original Assignee
Pliva, Farmaceutska Industrija, Dionicko Drustvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva, Farmaceutska Industrija, Dionicko Drustvo filed Critical Pliva, Farmaceutska Industrija, Dionicko Drustvo
Publication of IS6620A publication Critical patent/IS6620A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IS6620A 2000-05-19 2002-11-14 Nýr fjölgervingur V af tórasemíði IS6620A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20000328A HRP20000328A2 (en) 2000-05-19 2000-05-19 Novel polymorph v of torasemide
PCT/HR2000/000033 WO2001087841A1 (en) 2000-05-19 2000-09-25 Novel polymorph v of torasemide

Publications (1)

Publication Number Publication Date
IS6620A true IS6620A (is) 2002-11-14

Family

ID=10947111

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6620A IS6620A (is) 2000-05-19 2002-11-14 Nýr fjölgervingur V af tórasemíði

Country Status (32)

Country Link
US (2) US7241782B1 (is)
EP (1) EP1283828B1 (is)
JP (1) JP2003533512A (is)
KR (1) KR20030016267A (is)
CN (1) CN1520403A (is)
AP (1) AP2002002679A0 (is)
AR (1) AR028840A1 (is)
AT (1) ATE342890T1 (is)
AU (1) AU2000274381A1 (is)
BG (1) BG107407A (is)
BR (1) BR0015877A (is)
CA (1) CA2409699A1 (is)
CZ (1) CZ20024104A3 (is)
DE (1) DE60031450T2 (is)
DZ (1) DZ3356A1 (is)
EA (1) EA005003B1 (is)
EE (1) EE200200637A (is)
GE (1) GEP20043321B (is)
HR (1) HRP20000328A2 (is)
HU (1) HUP0302135A2 (is)
IL (1) IL152810A0 (is)
IS (1) IS6620A (is)
MA (1) MA25748A1 (is)
MX (1) MXPA02011402A (is)
NO (1) NO20025509D0 (is)
NZ (1) NZ522544A (is)
PL (1) PL358257A1 (is)
SK (1) SK17712002A3 (is)
TR (1) TR200202544T2 (is)
WO (1) WO2001087841A1 (is)
YU (1) YU84202A (is)
ZA (1) ZA200209181B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020025217A (ko) * 1999-08-11 2002-04-03 추후보정 토르세미드 동질이상
IN192178B (is) * 2001-08-03 2004-03-06 Ranbaxy Lab
US7067385B2 (en) * 2003-09-04 2006-06-27 Micron Technology, Inc. Support for vertically oriented capacitors during the formation of a semiconductor device
CN1824647B (zh) * 2005-02-22 2011-04-20 田边三菱制药株式会社 (±)2-(二甲基氨基)-1-{[O-(m-甲氧基苯乙基)苯氧基]甲基}乙基氢琥珀酸酯盐酸盐的晶体
CN100421662C (zh) * 2005-11-08 2008-10-01 周卓和 托拉塞米分散片及其制备方法和应用
CN104370805B (zh) * 2013-08-13 2016-09-07 天津汉瑞药业有限公司 托拉塞米化合物
CN105949115A (zh) * 2016-05-26 2016-09-21 南京正科医药股份有限公司 一种新晶型托拉塞米
CN115417810B (zh) * 2022-09-22 2023-10-10 南京正科医药股份有限公司 一种托拉塞米晶型ⅰ的精制方法
CN117486789A (zh) * 2023-12-29 2024-02-02 江西中医药大学 一种托拉塞米共晶盐及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1477664A (en) * 1974-04-17 1977-06-22 Christiaens Sa A Pyridine derivatives
US4055650A (en) 1974-04-17 1977-10-25 A. Christiaens Societe Anonyme Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridines
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
IN182496B (is) * 1996-02-20 1999-04-17 Reddy Research Foundation
HRP980532B1 (en) * 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
US5914336A (en) * 1998-06-02 1999-06-22 Boehringer Mannheim Gmbh Method of controlling the serum solubility of orally administered torasemide and composition relating thereto

Also Published As

Publication number Publication date
BR0015877A (pt) 2003-04-29
SK17712002A3 (sk) 2003-05-02
NZ522544A (en) 2004-07-30
YU84202A (sh) 2006-05-25
HRP20000328A2 (en) 2002-02-28
HUP0302135A2 (hu) 2003-10-28
BG107407A (en) 2004-01-30
EE200200637A (et) 2004-04-15
US20070238759A1 (en) 2007-10-11
TR200202544T2 (tr) 2003-03-21
EP1283828B1 (en) 2006-10-18
EP1283828A1 (en) 2003-02-19
MA25748A1 (fr) 2003-04-01
AP2002002679A0 (en) 2002-12-31
ZA200209181B (en) 2004-02-12
DE60031450D1 (de) 2006-11-30
CZ20024104A3 (cs) 2003-04-16
US7241782B1 (en) 2007-07-10
JP2003533512A (ja) 2003-11-11
NO20025509L (no) 2002-11-15
KR20030016267A (ko) 2003-02-26
DE60031450T2 (de) 2007-09-20
AR028840A1 (es) 2003-05-28
EA005003B1 (ru) 2004-10-28
PL358257A1 (en) 2004-08-09
ATE342890T1 (de) 2006-11-15
CA2409699A1 (en) 2001-11-22
WO2001087841A1 (en) 2001-11-22
AU2000274381A1 (en) 2001-11-26
EA200201236A1 (ru) 2003-04-24
GEP20043321B (en) 2004-04-13
CN1520403A (zh) 2004-08-11
NO20025509D0 (no) 2002-11-15
DZ3356A1 (en) 2001-11-22
IL152810A0 (en) 2003-06-24
MXPA02011402A (es) 2003-06-06

Similar Documents

Publication Publication Date Title
DK1438306T3 (da) Derivater af UK-2A
DK1360169T3 (da) Succinatsalt af O-desmethyl-venlafaxin
DK1307181T3 (da) Hidtil ukendte sammensætninger af minoxidil
PT1259508E (pt) Novos biarilcarboxamidas
DE60133503D1 (de) Stereomikroskop
ID30590A (id) Celana sekali pakai jenis-celana pendek
AR028567A1 (es) Nuevos derivados de fenil-propargileter
DK1226127T3 (da) Substituerede phenylsulfamoylcarboxamider
ATE307121T1 (de) Substituierte arylpyrazine
DE60123204D1 (de) Zoom-Objektiv
AR028596A1 (es) Nuevos derivados de fenilglicina
ID30187A (id) Dongkrak jenis pantagraf
AR028393A1 (es) Iminoazidas substituidas
DK1410012T3 (da) Bestemmelse af graviditetstilstand
NO20030917D0 (no) Anvendelse
DE60125415D1 (de) Formeinsatz
AR027983A1 (es) Novedosos compuestos
DE50100446D1 (de) Haftklebstoffe
AR028302A1 (es) Feniluracilos substituidos
IS6657A (is) Ný efnasambönd
AR028220A1 (es) Novedosos compuestos
DE50103366D1 (de) Polare Acrylathaftklebemassen
DE60007360T2 (de) Amorphe modifikation von torasemid
DK1373898T3 (da) Påvisning af inflammationer
DE10294532D2 (de) Künstlicher Lymphknoten